Heterologous COVID-19 Booster Vaccination in the Chronic Disorder of Consciousness: A Pilot Study

Significant anti-spike protein receptor-binding domain (S-RBD) antibody responses have been demonstrated in patients with chronic disorder of consciousness (DOC) completing a COVID-19 vaccine regime with BNT162b2 (Pfizer–BioNTech). We now provide further prospective data on the immunogenicity of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pugliese, Maria Elena, Battaglia, Riccardo, Raso, Maria Girolama, Chiaravalloti, Raffaela, Coschignano, Francesco, Pagliuso, Angela, Bruschetta, Roberta, Pugliese, Giovanni, Scola, Paolo, Tonin, Paolo, Cerasa, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149894/
https://www.ncbi.nlm.nih.gov/pubmed/35645314
http://dx.doi.org/10.3390/clinpract12030037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149894/
https://www.ncbi.nlm.nih.gov/pubmed/35645314
http://dx.doi.org/10.3390/clinpract12030037

Ejemplares similares